The genomic simplicity of differentiated cancers derived from thyroid follicular cells offers
unique insights into how oncogenic drivers impact tumour phenotype. Essentially, the main …

Thyroid nodules are common and the prevalence varies between 4 and 7% by palpation
and 19–68% by high-resolution USG. Most thyroid nodules are benign, and the malignancy …

Simple Summary Increasing awareness of thyroid cancer-related environmental risk factors
is considered an essential tool for cancer prevention through risk prevention/management …

Familial non-medullary thyroid carcinoma (FNMTC) accounts for 3% to 9% of all thyroid
cancer cases, yet its genetic mechanisms remain unknown. Our study aimed to screen and …

Cancer predisposition syndromes are entities determined especially by germinal pathogenic
variants, with most of them autosomal dominantly inherited. The risk of a form of cancer is …

This guideline is written as a reference document for clinicians presented with the challenge
of managing paediatric patients with differentiated thyroid carcinoma up to the age of 19 …

Familial non-medullary thyroid cancer (FNMTC) is a well-differentiated thyroid cancer (DTC)
of follicular cell origin in two or more first-degree relatives. Patients typically demonstrate an …

Approximately 5 to 15% of nonmedullary thyroid cancers (NMTC) present in a familial form
(familial nonmedullary thyroid cancers [FNMTC]). The genetic basis of FNMTC remains …

Purpose/Objective Thyroid cancer is the most common endocrine malignancy, accounting
for 1% of all cancers 1. The genetic syndromes associated with differentiated thyroid cancers …

Schilddrüsenkarzinome zählen mit einer jährlichen Inzidenz von 4, 1/100.000 Frauen und 1,
5/100.000 Männern zu den seltenen Krebserkrankungen und treten oft bereits im mittleren …